Area development of Schapenweide, Bilthoven with 450 homes and life sciences businesses
The Municipality of De Bilt and the Dutch Central Government Real Estate Agency (Rijksvastgoedbedrijf) have signed a purchase agreement for the development of Schapenweide in Bilthoven. Following the development framework established last year, this marks a significant step forward for the area. In addition to 450 homes, the plan includes space for life sciences businesses.
Schapenweide
Schapenweide covers 13.3 hectares and is located near the village centre of Bilthoven, adjacent to the Houdringe and Beerschoten estates and the Panbos nature area, a popular destination for both recreation and sport. The area will feature a broad mix of rental and owner-occupied housing, catering to a wide range of residents. Alongside the 450 homes, the development framework allows for 25,000 square metres of life sciences business space.
Few available sites in De Bilt
Schapenweide is one of the few remaining development locations within the Municipality of De Bilt. The local housing market is extremely tight, making it difficult for people to find suitable accommodation. The Central Government Real Estate Agency and the Municipality of De Bilt have worked constructively together to create a development framework for Schapenweide, after which AM was selected as the purchaser through a joint selection process.
“We are extremely pleased with this step and our collaboration with AM,” said Anne Marie ’t Hart, Alderman for the Municipality of De Bilt. “The sale of Schapenweide enables us to develop a future-proof and sustainable residential area that meets the growing demand for housing. We are confident that, together with AM, we can create a neighbourhood for the future.”
Inventum site and more
AM previously developed the former Inventum site in Bilthoven and is active in several other projects across the region, including the Merwedekanaalzone and Leidsche Rijn in Utrecht, as well as Hoef en Haag in the municipality of Vijfheerenlanden.
In the coming period, the development vision for Schapenweide will be translated into concrete plans, in close dialogue with stakeholders. Interested parties are welcome to register, including those who wish to contribute ideas.
Interview: Thomas Hoogeboom on the future of Mobility & Health
Healthcare in the Netherlands is at a turning point. The new Societal Impact Platform Mobility & Health aims to connect knowledge and expertise across research disciplines, organizations and societal partners. We spoke to Thomas Hoogeboom, Professor of Physiotherapy Sciences and initiator of the platform, about the importance of mobility for health, the value of collaboration and what to expect from the kick-off during Utrecht Science Week.
How UtrechtInc. helps startups grow
From a promising idea to a startup: getting there takes more than a good idea. UtrechtInc is a startup incubator that supports students, researchers and entrepreneurs in the Utrecht region during the early stages of their startup. Through validation programmes, personal guidance and a network of experts and investors, UtrechtInc helps founders develop and test their ideas.
The new sports season at Olympos has kicked off again
The holidays are over, and the sports season has kicked off again! With packed schedules and tight deadlines, it is tempting to just keep working. Before you know it, you’ve spent hours in front of your screen or in the lab without taking a real break. Especially when things are busy, physical activity can help you unwind and gain new energy and inspiration.
Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals
On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).